Shares of AGF U.S. Market Neutral Anti-Beta Fund (NYSEARCA:BTAL – Get Free Report) rose 1% on Friday . The stock traded as high as $18.31 and last traded at $18.31. Approximately 250,826 shares changed hands during trading, a decline of 60% from the average daily volume of 629,997 shares. The stock had previously closed at $18.12.
AGF U.S. Market Neutral Anti-Beta Fund Stock Performance
The company has a 50 day moving average of $18.43 and a two-hundred day moving average of $19.32. The stock has a market capitalization of $261.83 million, a PE ratio of 15.45 and a beta of -0.85.
Institutional Inflows and Outflows
A number of hedge funds have recently bought and sold shares of the stock. VitalStone Financial LLC grew its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 48.5% during the third quarter. VitalStone Financial LLC now owns 85,335 shares of the company’s stock valued at $1,673,000 after buying an additional 27,885 shares during the last quarter. Magnolia Private Wealth LLC acquired a new stake in AGF U.S. Market Neutral Anti-Beta Fund during the 4th quarter worth about $331,000. Creative Financial Designs Inc. ADV lifted its position in AGF U.S. Market Neutral Anti-Beta Fund by 8.8% during the 3rd quarter. Creative Financial Designs Inc. ADV now owns 158,626 shares of the company’s stock worth $3,109,000 after acquiring an additional 12,788 shares during the period. Ethos Financial Group LLC grew its stake in AGF U.S. Market Neutral Anti-Beta Fund by 49.1% during the 4th quarter. Ethos Financial Group LLC now owns 20,225 shares of the company’s stock valued at $386,000 after purchasing an additional 6,663 shares during the last quarter. Finally, Worth Asset Management LLC increased its holdings in shares of AGF U.S. Market Neutral Anti-Beta Fund by 16.2% in the third quarter. Worth Asset Management LLC now owns 41,346 shares of the company’s stock valued at $810,000 after purchasing an additional 5,760 shares during the period.
About AGF U.S. Market Neutral Anti-Beta Fund
The AGFiQ U.S. Market Neutral Anti-Beta Fund (BTAL) is an exchange-traded fund that mostly invests in long\u002Fshort alternatives. The fund is an actively managed fund that takes long positions in low beta US stocks, offset by short positions in high beta US stocks. BTAL was launched on Sep 13, 2011 and is managed by AGF.
Featured Articles
- Five stocks we like better than AGF U.S. Market Neutral Anti-Beta Fund
- Most active stocks: Dollar volume vs share volume
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- Election Stocks: How Elections Affect the Stock Market
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Insider Buying Explained: What Investors Need to Know
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for AGF U.S. Market Neutral Anti-Beta Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AGF U.S. Market Neutral Anti-Beta Fund and related companies with MarketBeat.com's FREE daily email newsletter.